利用分子动力学,物理化学和结构分析来探索OMP33-36蛋白作为Acinetobacter baumannii的药物标:对抗医院感染的方法
Sukriti Singh1, Jyotsna Agarwal2, Anupam Das2
1Amity Institute of Biotechnology, Amity University Uttar Pradesh, Lucknow Campus, Gomtinagar Extension, Lucknow, 226028, India.
Journal of molecular graphics & modelling
|January 25, 2025
概括
研究人员确定了奎尔塞丁和塔马里克塞丁作为潜在的药物,在多药耐药的Acinetobacter baumannii感染中准Omp33-36蛋白质. 这些有前途的植物化合物需要进一步验证.
科学领域:
- 微生物学 微生物学
- 计算化学计算化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 宝曼尼菌 (Acinetobacter baumannii) 是多抗药性 (MDR) 感染的主要原因,特别是在医疗机构.
- 外膜蛋白33-36 (Omp33-36) 蛋白是对抗A. baumannii的潜在治疗标.
- 植物化合物为开发新型抗菌剂提供了一个有希望的途径.
研究的目的:
- 通过使用in-silico药物选来确定针对A. baumannii中的Omp33-36蛋白的潜在治疗剂.
- 评估针对Omp33-36受体的选择植物化合物的药物相似性和结合亲和力.
- 通过分子动态模拟来评估顶级化合物的稳定性和相互作用.
主要方法:
- 来自Andrographis paniculata,Cascabela thevetia和Prosopis cineraria的植物化合物对A. baumannii Omp33-36进行内选.
- 使用swissADME和ProTox进行物理化学表征和毒性评估.
- 使用Autodock Vina和200ns的分子动态模拟进行分子对接.
主要成果:
- 15种植物化合物表现出显著的药物相似性.
- 七种化合物对Omp33-36表现出强烈的结合亲和力,对接分数从-7.2到-7.9kcal/mol不等.
- 在分子动力学模拟过程中,奎尔塞丁和塔马里克塞丁表现出一致的相互作用和高结合能 (-18~-33 kcal/mol).
结论:
- 奎尔塞丁和塔马里克塞丁显示出显著的希望,作为潜在的治疗方法,通过向Omp33-36蛋白来调节A. baumannii感染.
- 这项研究强调了在体中药物查的潜力,用于识别新型抗菌植物化合物.
- 在体外和体外实验验证是确认这些已识别的植物分子治疗功效的关键下一步.
更多相关视频
08:37The Application of Open Searching-based Approaches for the Identification of Acinetobacter baumannii O-linked Glycopeptides
Published on: November 2, 2021
2.1K
05:06Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
526
相关概念视频
01:28Gene Regulation in Microbial Communities: Quorum Sensing
960
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
960
01:25Mechanism of Antibiotic Resistance in MRSA
245
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
245